We propose to synthesize potent and stable opioid peptide analogs, designed to be i) highly selective delta antagonists without mu antagonist properties, ii) mixed mu agonists/delta antagonists and iii) structurally rigid mu-selective agonists. The compounds to be developed might also be useful for the further demonstration of putative mu-, delta- and kappa-opioid receptor subtypes and as selective ligands for such subtypes. Highly receptor-selective opioid peptide agonists, antagonists or mixed agonists/antagonists are needed in studies aimed at correlating specific opioid effects with a distinct receptor class or subclass as well as for the development of potential therapeutic agents showing minimal side effects. to reach these goals, we use an interdisciplinary approach incorporating peptide synthesis, conformational investigations and extensive pharmacological characterization. The peptide analog design will be based on various principles, including substitution of natural and artificial amino acids, peptide bond replacements and introduction of conformational constraints.
Specific aims i nclude: a) synthesis of highly potent and stable analogs of the delta-selective prototype antagonists H-Tyr-Tic-Phe-Phe-OH (TIPP) and H-Tyr-Tic-Phe-OH (TIP) recently discovered in our laboratory; b) development of mixed mu agonists/delta antagonists based on structural modification of H-Tyr-Tic-Phe-Phe-NH2 (TIPP-NH2) or H-Tyr-cyclo[-D-Orn-1- Nal-D-Pro-Gly-] and on the preparation of peptide dimers; and c) synthesis of analogs of the mu-selective cyclic dermorphin peptide H-Tyr- D-Orn-Phe-Asp(or Glu)-NH2 containing additional conformational constraints at the Tyr1- and/or Phe3- residue or in the peptide ring structure; d) conformational studies by molecular mechanics and molecular dynamics techniques, and by 1- and 2-dimensional NMR spectroscopic methods; e) determination of receptor affinities and selectivities of the new compounds in binding assays based on displacement of mu-, delta- and kappa-selective radioligands from rat or guinea pig brain membrane binding sites; f) evaluation of agonist and antagonist properties of the analogs in bioassays based on inhibition of electrically evoked contractions of the guinea pig ileum and of the vasa deferentia of the mouse, rat and rabbit; g) examination of the stability of the compounds against enzymatic degradation; and h) tests of the analgesic properties of the analogs using the mouse writhing and hot plate assays.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004443-09
Application #
2117203
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1987-06-01
Project End
1996-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
9
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Clinical Research Institute of Montreal
Department
Type
DUNS #
City
Montreal
State
QC
Country
Canada
Zip Code
H2 1-R7
Willemse, Tom; Eiselt, Emilie; Hollanders, Karlijn et al. (2018) Chemical space screening around Phe3 in opioid peptides: Modulating µ versus ? agonism by Suzuki-Miyaura cross-couplings. Bioorg Med Chem Lett 28:2320-2323
Stoeber, Miriam; Jullié, Damien; Lobingier, Braden T et al. (2018) A Genetically Encoded Biosensor Reveals Location Bias of Opioid Drug Action. Neuron 98:963-976.e5
Toyama, Satoshi; Shimoyama, Naohito; Szeto, Hazel H et al. (2018) Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice. ACS Chem Neurosci 9:1566-1571
Starnowska, Joanna; Costante, Roberto; Guillemyn, Karel et al. (2017) Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice. ACS Chem Neurosci 8:2315-2324
Van der Poorten, Olivier; Van Den Hauwe, Robin; Eiselt, Emilie et al. (2017) ?-Space Screening of Dermorphin-Based Tetrapeptides through Use of Constrained Arylazepinone and Quinolinone Scaffolds. ACS Med Chem Lett 8:1177-1182
Tan, Paul; Blais, Carolane; Nguyen, Thi M-D et al. (2016) Prorenin/renin receptor blockade promotes a healthy fat distribution in obese mice. Obesity (Silver Spring) 24:1946-54
Cai, Yunxin; Lu, Dandan; Chen, Zhen et al. (2016) [Dmt(1)]DALDA analogues modified with tyrosine analogues at position 1. Bioorg Med Chem Lett 26:3629-31
Weltrowska, Grazyna; Nguyen, Thi M-D; Chung, Nga N et al. (2016) A Cyclic Tetrapeptide (""Cyclodal"") and Its Mirror-Image Isomer Are Both High-Affinity ? Opioid Receptor Antagonists. J Med Chem 59:9243-9254
Guillemyn, Karel; Starnowska, Joanna; Lagard, Camille et al. (2016) Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain. J Med Chem 59:3777-92
Gendron, Louis; Cahill, Catherine M; von Zastrow, Mark et al. (2016) Molecular Pharmacology of ?-Opioid Receptors. Pharmacol Rev 68:631-700

Showing the most recent 10 out of 103 publications